Polycystic Kidney Diseases Clinical Trial
Official title:
Autosomal Dominant Polycystic Kidney Disease Patient Registry
The purpose of the ADPKD Registry is to create an online patient network that includes at least 5,000 people with Autosomal Dominant Polycystic Kidney Disease (ADPKD) who contribute data on their health and other topics. The ADPKD Patient Registry aims to support important scientific discoveries and support patient needs in the following ways: - Connect ADPKD patients with opportunities to join clinical studies. - Collect data for the research community to better describe the ADPKD disease experience and improve patient care. - Engage with patients by measuring quality of life outcomes.
The ADPKD Registry will be a patient-powered network of people with ADPKD. This data will inform new research to improve ADPKD patient outcomes, learn more about the patient journey and discover unmet medical needs. We collect data most relevant to your ADPKD diagnosis, its major symptoms and management, as well as key demographic data (no personally identifiable information is shared). A Registry keeps information in one place making it easier for researchers to utilize Registry information while still protecting the privacy of those who take part. The Registry will be hosted on a secure, online platform that patients can access using their home computers, tablets or phones. The purpose of the ADPKD Registry is to allow PKD patients to: - Connect with researchers and express interest in taking part in certain clinical studies for ADPKD, including studies of new medications and other treatments. - Take confidential health-related surveys. These surveys are aimed at better understanding of the health of people with PKD across their lifespans. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Enrolling by invitation |
NCT05215964 -
The Association Between Skeletal Muscle Mass and Severity of Polycystic Liver Disease and Polycystic Kidney Disease
|
||
| Recruiting |
NCT01680250 -
Sirolimus for Massive Polycystic Liver
|
Phase 2/Phase 3 | |
| Completed |
NCT00286156 -
Pilot Study of Rapamycin as Treatment for Autosomal Dominant Polycystic Kidney Disease (ADPKD)
|
Phase 1/Phase 2 | |
| Not yet recruiting |
NCT06036992 -
Study and Management of Cystic Complications in Autosomal Dominant Polycystic Kidney Disease
|
||
| Terminated |
NCT01009957 -
Everolimus on CKD Progression in ADPKD Patients
|
Phase 2/Phase 3 | |
| Completed |
NCT01931644 -
At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic Conditions
|
||
| Completed |
NCT02739750 -
Pioglitazone and Lumbar Bone Marrow Fat in Chronic Kidney Disease
|
||
| Completed |
NCT03889392 -
Evaluation of Nephrectomy Specimen for Intracranial Aneurysm Development in ADPKD
|
||
| Completed |
NCT03948113 -
Outcome of Autosomal Dominant Polycystic Kidney Disease Patients on Peritoneal Dialysis: a National Retrospective Study Based on Two French Registries (the French Language Peritoneal Dialysis Registry and the French Renal Epidemiology and Information Network).
|
||
| Recruiting |
NCT03726463 -
Evaluation of Iliac and Renal Artery for Mechanism of Intracranial Aneurysm in ADPKD
|
||
| Completed |
NCT03423810 -
Assessing a Dose‐Response Relationship of Hydralazine and Its Effects on DNA Methyltransferase 1 in Polycystic Kidney Disease Patients
|
Early Phase 1 |